← Back to headlines
OraSure Expects Q3 Revenue of $29.5M-$32.5M, Delays FDA Clearance
OraSure Technologies projects its third-quarter revenue to be between $29.5 million and $32.5 million, while also announcing a delay in the FDA clearance for its InteliQuick CT/NG product beyond 2026.
6 Aug, 13:45 — 6 Aug, 13:45
Sources
Showing 1 of 1 sources
